15 / 30
How? Low-molecular weight heparins/ fondaparinux
19,5%
8,3%
3,9%
9,7%
3,0%
17,0%
0%
5%
10%
15%
20%
MEDENOX PREVENT ARTEMIS
Placebo
LMWH
RR = 0.50
NNT =
10
RR = 0.37
NNT =
18
Carrier M,
et al.
Am J Med. 2014 Jan;127(1):82-6.e1
Cancer subgroups of medical thromboprophylaxis trials
RR = 4.3
NNT =
8
* fondaparinux
*
Prevention of VTE in cancer patients
15
/
fondaparinux